Table 3.
n1:n2:n3 | AD |
MCI |
NC |
ANOVA |
Post-hoc groupwise (LSD) |
|||||
---|---|---|---|---|---|---|---|---|---|---|
(N = 25) | (N = 29) | (N = 34) | F | Df | p | AD vs NC | MCI vs NC | AD vs MCI | ||
ATR_L | 24:29:34 | 0.802 ± 0.092 | 0.771 ± 0.051 | 0.742 ± 0.04 | 6.661 | 86 | 0.002⁎⁎⁎⁎ | <0.001⁎ | 0.066 | 0.074 |
ATR_R | 25:29:34 | 0.778 ± 0.094 | 0.770 ± 0.076 | 0.748 ± 0.061 | 1.210 | 87 | 0.303 | 0.146 | 0.270 | 0.699 |
CST_L | 25:29:34 | 0.774 ± 0.051 | 0.755 ± 0.030 | 0.743 ± 0.031 | 4.845 | 87 | 0.010⁎⁎ | 0.003⁎ | 0.223 | 0.066 |
CST_R | 25:29:34 | 0.759 ± 0.055 | 0.742 ± 0.031 | 0.730 ± 0.028 | 3.892 | 87 | 0.024⁎⁎ | 0.007⁎ | 0.233 | 0.118 |
CCing_L | 23:28:33 | 0.800 ± 0.055 | 0.790 ± 0.038 | 0.766 ± 0.040 | 4.472 | 83 | 0.014⁎⁎ | 0.006⁎ | 0.039⁎ | 0.419 |
CCing_R | 20:27:33 | 0.773 ± 0.045 | 0.766 ± 0.044 | 0.741 ± 0.034 | 4.769 | 79 | 0.011⁎⁎ | 0.007⁎ | 0.021⁎ | 0.545 |
CHippo_L | 9:15:22 | 0.815 ± 0.049 | 0.786 ± 0.073 | 0.751 ± 0.044 | 4.581 | 45 | 0.016⁎⁎ | 0.006⁎ | 0.067 | 0.235 |
CHippo_R | 12:19:30 | 0.795 ± 0.034 | 0.744 ± 0.054 | 0.744 ± 0.060 | 4.274 | 60 | 0.019⁎⁎ | 0.008⁎ | 0.990 | 0.013⁎ |
CC Splenium | 21:27:33 | 0.883 ± 0.085 | 0.849 ± 0.07 | 0.853 ± 0.068 | 1.499 | 80 | 0.230 | 0.148 | 0.815 | 0.111 |
CC Genu | 24:27:34 | 0.845 ± 0.054 | 0.833 ± 0.057 | 0.824 ± 0.046 | 1.154 | 84 | 0.320 | 0.133 | 0.494 | 0.419 |
IFOF_L | 22:26:34 | 0.864 ± 0.059 | 0.818 ± 0.035 | 0.798 ± 0.035 | 16.124 | 81 | <0.001⁎⁎ | <0.001⁎ | 0.072 | <0.001⁎ |
IFOF_R | 23:27:31 | 0.840 ± 0.078 | 0.800 ± 0.046 | 0.778 ± 0.033 | 9.028 | 80 | <0.001⁎⁎ | <0.001⁎ | 0.118 | 0.010⁎ |
ILF_L | 23:29:34 | 0.859 ± 0.081 | 0.824 ± 0.047 | 0.802 ± 0.039 | 7.240 | 85 | 0.001⁎⁎ | <0.001⁎ | 0.131 | 0.024⁎ |
ILF_R | 24:28:34 | 0.811 ± 0.056 | 0.791 ± 0.057 | 0.776 ± 0.037 | 3.495 | 85 | 0.035⁎⁎ | 0.010⁎ | 0.253 | 0.143 |
SLF_L | 23:29:34 | 0.762 ± 0.065 | 0.747 ± 0.033 | 0.722 ± 0.029 | 6.493 | 87 | 0.002⁎⁎ | 0.001⁎ | 0.022⁎ | 0.226 |
SLF_R | 25:29:34 | 0.768 ± 0.052 | 0.763 ± 0.055 | 0.747 ± 0.027 | 1.667 | 87 | 0.195 | 0.091 | 0.187 | 0.678 |
UF_L | 25:29:34 | 0.854 ± 0.043 | 0.823 ± 0.039 | 0.808 ± 0.048 | 8.084 | 87 | 0.001⁎⁎ | <0.001⁎ | 0.177 | 0.011⁎ |
UF_R | 24:29:34 | 0.843 ± 0.083 | 0.800 ± 0.042 | 0.770 ± 0.040 | 12.133 | 86 | <0.001⁎⁎ | <0.001⁎ | 0.038⁎ | 0.006⁎ |
AF_L | 24:28:34 | 0.769 ± 0.055 | 0.751 ± 0.029 | 0.733 ± 0.029 | 6.777 | 85 | 0.002⁎⁎ | <0.001⁎ | 0.069 | 0.071 |
AF_R | 24:25:33 | 0.759 ± 0.066 | 0.753 ± 0.035 | 0.737 ± 0.024 | 2.130 | 81 | 0.126 | 0.056 | 0.146 | 0.649 |
Note: Unless otherwise specified, data reflect the MD values × 10−3 mm2 s−1 presented as means ± standard deviations. AD, Alzheimer's disease; MCI, mild cognitive impairment; NC, normal control; ATR, anterior thalamic; CST, corticospinal tract; CCing, cingulum cingulate; CHippo, cingulum hippocampus; CC, corpus callosum; IFOF, inferior fronto-occipital fasciculus; ILF, inferior longitudinal fasciculus; SLF, superior longitudinal fasciculus; UF, uncinated fasciculus; AF, arcuate fasciculus. L, left; R, right. Least significant difference test was used in multiple comparisons. n1: n2: n3 means the successfully traced number of AD, MCI, and NC subjects in each fiber.
Significant difference with a p value <.05 with Post-hoc LSD multiple comparisons.
Significant difference with a p value <.05(FDR corrected).